DPG Mitgliedschaft
This block is broken or missing. You may be missing content or you might need to enable the original module.
Keyword: Amgen
News
10.03.2021
-
Amgen is to buy Five Prime Therapeutics, a clinical-stage biotech focused on developing immuno-oncology and targeted cancer therapies, for about $1.9 billion. The...
News
04.11.2019
- US biotech Amgen has agreed to take a 20.5% stake in China’s BeiGene as the two companies enter into a strategic collaboration to develop cancer drugs. The move significantly...
News
27.08.2019
- Contrary to recent speculation that Amgen was preparing to buy Alexion, the California-based US biotech has announced that it instead will acquire Celgene’s Otezla, the only oral...
News
19.08.2019
- The US District Court for the District of New Jersey has upheld two of Amgen’s patents for its top-selling drug Enbrel (etanercept) in a ruling against Sandoz, which has been...
News
10.05.2019
- The US market watchdog Public Citizen has sued the Food and Drug Administration (FDA), demanding that a district court in Washington, DC, require the agency to add “black box”...
News
17.04.2019
- Swiss drugmaker Novartis and US biopharma Amgen are embroiled in a legal dispute regarding their collaboration on migraine prevention drug Aimovig. Novartis has filed a complaint...
News
05.07.2018
- The US Food and Drug Administration‘s (FDA) recent approval of a new migraine treatment marketed by Amgen and Novartis has met with an enthusiastic response since it was...
News
25.04.2017
- Pharma chiefs are urging European heads of state to decide sooner rather than later on the new location for the European Medicines Agency (EMA), which is due to leave the UK as a...
Ehrenamtliches Engagement
This block is broken or missing. You may be missing content or you might need to enable the original module.
